Collectively, these results support a dual role for HOXA5 in promoting proliferation while restraining the tumor’s invasive and angiogenic capacity, potentially explaining the improved survival observed despite increased Ki-67 expression. The gene discussed is HOXA5; the disease is neoplasm.